Omeprazole/antacids swallowable tablet - Salix Pharmaceuticals
Alternative Names: Magnesium hydroxide/sodium bicarbonate/omeprazole; Omeprazole/antacids; Sodium bicarbonate/omeprazole/magnesium hydroxide; Zegerid swallowable tabletsLatest Information Update: 14 Jan 2014
At a glance
- Originator Santarus
- Developer Salix Pharmaceuticals
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Gastric antisecretories; Small molecules
- Mechanism of Action Antacids; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gastrointestinal disorders; Heartburn
Most Recent Events
- 02 Jan 2014 Santarus has been acquired and merged into Salix Pharmaceuticals
- 31 Oct 2011 Norgine completes a phase III trial in Heartburn in Poland (NCT01493089)
- 08 Sep 2011 Norgine completes a phase III trial in Heartburn in Bulgaria, Czech Republic, UK and Hungary (EudraCT 2010-022082-10)